We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $30.5 · 4 analysts
Stored first · Google News · Yahoo Finance (English)
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX - MarketBeat
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX MarketBeat
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near Resistance - MFI Overbought - dars.gov.et
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near Resistance - MFI Overbought dars.gov.et
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - MSN
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade MSN
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings - Stock Titan
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings Stock Titan
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index marketscreener.com
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 04. | After market close (AMC) | — | — | — | $25.96M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-1.52 | — | — | $17.96M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-5.61 | — | — | $50.89M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.22 | — | — | $32.74M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 06. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 02. 28. | William Blair | — | Upgrade | Market Perform → Outperform | — | William Blair: Market Perform → Outperform |
| 2026. 02. 18. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2025. 09. 20. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2025. 05. 22. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2025. 05. 15. | Craig-Hallum | — | Maintain | Buy → Buy | — | Craig-Hallum: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 45,231 | $655.85K | 0.00% | — | New position |